CA9 and neoplasm: Since hypoxia induced by anti-angiogenic therapy may stimulate resistance-promoting adaptations—including the expression of CAIX—by tumor cells, targeting these effectors in combination with inhibitors of angiogenesis may induce a specific form of synthetic lethality called induced essentiality (aka contextual synthetic lethality) [27,28].